Agilent Technologies, Inc. has been upgraded to a Zacks Rank #2, reflecting growing confidence despite recent challenges including a 6% share drop and tariff pressures. The company is projected to maintain earnings of $5.95 per share for the fiscal year ending October 2026, unchanged from the previous year, while its market cap has risen to $31.57 billion. Agilent's commitment to providing analytical solutions in life sciences and diagnostics, coupled with a flawless balance sheet, underscores its strategic resilience and potential for future growth.
“Agilent Technologies Inc. · will participate in · a fireside chat · at the Jefferies Global Healthcare Conference”
“Agilent Technologies, Inc. · is a · global leader in analytical and clinical laboratory technologies”
“Alcoa Corp (AA) · shares · down · 6%”
“Agilent Technologies · has been upgraded to · Zacks Rank #2 · Buy”
“Agilent for the fiscal year ending October 2026 · is expected to earn · $5.95 per share · unchanged compared with the year-ago reported number”
“Agilent Technologies, Inc. · engages in the provision of · application focused solutions · life sciences, diagnostics, and applied chemical markets”
“Agilent Technologies, Inc. · has · CEO · Padraig Mcdonnell”
“Agilent Technologies, Inc. · is headquartered in · Santa Clara, California”
“Agilent Technologies, Inc. · has a trading volume of · 1.38M”
“Agilent Technologies · has · 30-day share price return · down 4.05%”
“Agilent Technologies · has · year-to-date share price return · down 18.27%”
“Agilent Technologies · has · 1-year total shareholder return · 1.92%”